Exhibit 99.1 MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update $19 million revenue in 2023; $24 million projected revenue in 2024 NexoBrid® commercially launched in U.S., Japan, India Potential blockbuster EscharEx® to begin Phase III in the second half of 2024 $42 million cash runway through profitability Conference call today, March 21 at 8:30am Eastern Time YAVNE, Israel, March 21, 2024 -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation ...